We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMAN
1126
DELISTED
eMagin Corporation
EMAN
$170K ﹤0.01%
261,300
– –
PRPH
1127
DELISTED
ProPhase Labs
PRPH
$167K ﹤0.01%
+1,320
New +$116K
PYXS icon
1128
Pyxis Oncology
PYXS
$238M
$167K ﹤0.01%
+70,295
New +$187K
VIRC icon
1129
Virco
VIRC
$95.2M
$167K ﹤0.01%
43,400
– –
CVGI icon
1130
Commercial Vehicle Group
CVGI
$148M
$165K ﹤0.01%
28,300
– –
OBCI
1131
DELISTED
Ocean Bio-Chem Inc
OBCI
$165K ﹤0.01%
12,798
– –
CRD.B icon
1132
Crawford & Co Class B
CRD.B
$563M
$164K ﹤0.01%
23,201
– –
SURF
1133
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$164K ﹤0.01%
100,000
– –
LHDX
1134
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$163K ﹤0.01%
+87,700
New +$213K
IMBI
1135
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$162K ﹤0.01%
134,117
+95,000
+243% +$271K
AUMN
1136
DELISTED
Golden Minerals Company
AUMN
$161K ﹤0.01%
18,000
– –
BDTX icon
1137
Black Diamond Therapeutics
BDTX
$110M
$160K ﹤0.01%
65,200
-12,000
-16% -$27.9K
HCWB icon
1138
HCW Biologics
HCWB
$5.45M
$160K ﹤0.01%
303
+67
+28% +$37.6K
EVK
1139
DELISTED
Ever-Glory International Group, Inc.
EVK
$160K ﹤0.01%
116,500
– –
CRVS icon
1140
Corvus Pharmaceuticals
CRVS
$1.17B
$158K ﹤0.01%
159,300
– –
AGNT
1141
AGNT Inc
AGNT
$690M
$158K ﹤0.01%
13,400
– –
LSEA
1142
DELISTED
Landsea Homes
LSEA
$157K ﹤0.01%
+23,500
New +$183K
INFI
1143
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$157K ﹤0.01%
249,000
-31,000
-11% -$23.8K
STTK icon
1144
Shattuck Labs
STTK
$684M
$156K ﹤0.01%
+38,400
New +$139K
ELVN icon
1145
Enliven Therapeutics
ELVN
$4.31B
$154K ﹤0.01%
31,625
-3,875
-11% -$19K
MBIO icon
1146
Mustang Bio
MBIO
$4.36M
$154K ﹤0.01%
350
-67
-16% -$37.1K
KTCC icon
1147
Key Tronic
KTCC
$44.7M
$153K ﹤0.01%
34,800
– –
HMTV
1148
DELISTED
Hemisphere Media Group, Inc.
HMTV
$153K ﹤0.01%
20,000
– –
INUV icon
1149
Inuvo
INUV
$16.8M
$151K ﹤0.01%
30,600
– –
STCN
1150
DELISTED
Steel Connect, Inc. Common Stock
STCN
$151K ﹤0.01%
12,091
-16,071
-57% -$191K
44 45
46
47 48

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.